INDIVIOR INC FDA Approval NDA 018401

NDA 018401

INDIVIOR INC

FDA Drug Application

Application #018401

Documents

Letter2002-03-08
Letter2003-06-22
Review2006-05-10
Review2006-10-26
Letter2016-12-19
Label2019-10-07
Letter2019-10-09
Letter2022-06-21
Label2022-06-21

Application Sponsors

NDA 018401INDIVIOR INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 0.3MG BASE/ML1BUPRENEXBUPRENORPHINE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1981-12-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1982-10-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1985-05-17STANDARD
LABELING; LabelingSUPPL4AP1987-02-13
LABELING; LabelingSUPPL5AP1987-11-19
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1989-03-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1989-12-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1994-04-29STANDARD
LABELING; LabelingSUPPL11AP1993-06-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1995-02-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1995-11-29STANDARD
LABELING; LabelingSUPPL14AP2002-02-11STANDARD
LABELING; LabelingSUPPL15AP2003-06-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP2013-01-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2014-02-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2013-08-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2015-05-11STANDARD
LABELING; LabelingSUPPL22AP2016-12-16STANDARD
LABELING; LabelingSUPPL25AP2019-10-07STANDARD
LABELING; LabelingSUPPL26AP2022-06-17STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL6Null0
SUPPL8Null0
SUPPL10Null0
SUPPL12Null0
SUPPL13Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL22Null15
SUPPL25Null6
SUPPL26Null7

TE Codes

001PrescriptionAP

CDER Filings

INDIVIOR INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18401
            [companyName] => INDIVIOR INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUPRENEX","activeIngredients":"BUPRENORPHINE HYDROCHLORIDE","strength":"EQ 0.3MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"10\/07\/2019","submission":"SUPPL-25","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/018401s025lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"BUPRENEX","submission":"BUPRENORPHINE HYDROCHLORIDE","actionType":"EQ 0.3MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-10-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.